- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Capex | Q1 2026 · Mar 31, 2026 | $7.85M |
| Capex | Q1 2026 · Mar 31, 2025 | $6.8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$169.35M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$176.75M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.11B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.1B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $277.42M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $337.23M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $371.48M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $337.3M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $386.01M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $469.3M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $506.61M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.91B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.47B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.25B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.86B |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $46.88M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $44.13M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$37.49M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$21.9M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $2.08M |